What an mRNA melanoma vaccine may mean for cancer treatment

Episode 1385

0:00-11:54

A new mRNA vaccine for melanoma is making headlines. Moderna and Merck recently announced results from their clinical trial suggesting that this new vaccine, in combination with the cancer drug Keytruda, reduced recurrence rates in patients. The companies have not yet released full data from the trial. So, how does the vaccine work? And does this mark the beginning of a new era of cancer treatments using mRNA vaccine technology? Ira talks with physician Michael Postow, whose patients were part of the drug trial at Memorial Sloan Kettering Cancer Center. Guest: Dr. Michael...

Publisher

Science Friday

Link

www.wnycstudios.org/podcasts/science-friday

Published

September 3, 2026

Duration

12 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

Host

Science Friday and WNYC Studios

SF

Science Friday

@sciencefriday

#mrnamelanomavaccine #cancertreatment

The Nile